Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medtronic revenue decreased from $30.6 billion in 2019 to $28.9 billion in 2020, a (5.4%) decrease.

Annual Revenue ($)

Medtronic revenue was $28.91 b in FY, 2020 which is a (5.4%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$29.95 b$30.56 b$28.91 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021
Revenue$7.38 b$7.48 b$7.55 b$7.49 b$7.71 b$7.72 b$6.51 b$7.65 b$7.78 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Medtronic revenue breakdown by business segment: 8.2% from Diabetes Group, 28.9% from Minimally Invasive Therapies Group, 36.2% from Cardiac and Vascular Group and 26.7% from Restorative Therapies Group

Medtronic revenue breakdown by geographic segment: 51.6% from United States, 32.1% from Non-U.S. Developed Markets and 16.3% from Emerging Markets

FY, 2020FY, 2019FY, 2018
Minimally Invasive Therapies Group$8.35 b$8.48 b$8.72 b
Cardiac and Vascular Group $10.47 b$11.51 b$11.35 b
Restorative Therapies Group$7.73 b$8.18 b$7.74 b
Diabetes Group$2.37 b$2.39 b$2.14 b
FY, 2020FY, 2019FY, 2018
United States$14.92 b$16.19 b$15.88 b
Ireland $91 m$85 m
Rest of World$14.27 b$13.99 b
Non-U.S. Developed Markets$9.29 b
Emerging Markets$4.71 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu